跳至主要内容
临床试验/JPRN-UMIN000027827
JPRN-UMIN000027827招募中未知

Multi-Modal study for the Maintenance of Remission after Electroconvulsive therapy (ECT) - Multi-Modal study for the Maintenance of Remission after Electroconvulsive therapy (ECT)

Department of Neuropsychiatry, Keio University School of Medicine0 个研究点目标入组 100 人开始时间: 2017年6月20日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1, With internal metals or pacemakers 2, With serious physical disorders 3, History of head injury with severe neurological sequelae 4, Pregnant

研究者

发起方
Department of Neuropsychiatry, Keio University School of Medicine

相似试验

已完成
不适用
Observational Cohort Study of Remission Maintenance Therapy in Japanese Patients with ANCA-associated VasculitisANCA-associated vasculitis
JPRN-UMIN000006373Research Committe of Intractable Vasculitis Syndrome of the Ministry of Health, Labor and Welfare of Japan150
进行中(未招募)
不适用
A 3-Phase Study to Evaluate Sustained Remission and Productivity Outcomes in Subjects With Early Rheumatoid Arthritis Initiated on Treatment With Etanercept Plus Methotrexate - PRIZEModerate to severe early Rheumatoid Arthritis (RA).MedDRA version: 12.0Level: LLTClassification code 10039073Term: Rheumatoid arthritis
EUCTR2008-002623-85-ITWyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development300
已完成
不适用
Multicenter prospective cohort study of remission induction and maintainance effects of anti-TNFagents for Crohn's jejunoileitis.Suspected and documented Cron&#39s jejunoileitis
JPRN-UMIN000008486agoya University Graduate School of Medicine, Department of Gastroenterology and Hepatology400
招募中
不适用
Investigation on the remission maintaining effect of Polaprezinc in patients with Crohn's disease in remission phase.Patients with Crohn&#39s disease in remission phase
JPRN-UMIN000005970Kawasaki Medical School100
进行中(未招募)
1 期
A 3-PHASE STUDY TO EVALUATE SUSTAINED REMISSION AND PRODUCTIVITY OUTCOMES IN SUBJECTS WITH EARLY RHEUMATOID ARTHRITIS INITIATED ON TREATMENT WITH ETANERCEPT PLUS METHOTREXATE Estudio en 3 fases para evaluar el mantenimiento de la remisión y los parámetros de productividad en sujetos con artritis reumatoide en fase inicial que comiencen tratamiento con etanercept más metotrexato.Moderate to severe early Rheumatoid Arthritis (RA).(Subjects with moderate to severe early Rheumatoid Arthritis (RA), who are currently employed (to constitute a majority of recruited subjects), or if not employed, are able to work and perform a functional role in society, such as caring for home and family, who have had RA symptoms for 1 year or less, and are Methotrexate-naive).Artritis reumatoideMedDRA version: 9.1Level: LLTClassification code 10039073Term: Rheumatoid arthritis
EUCTR2008-002623-85-ESWyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development300